Search results
Satish Mehta is the first-generation entrepreneur and visionary who started Emcure in 1981 with the purpose to provide affordable and high quality healthcare to patients to significantly improve their lives.
4 days ago · Attorneys general of 45 states are seeking to add Satish Mehta, the billionaire CEO of Emcure Pharmaceuticals, and Rajiv Malik, the president of Mylan, to a nearly year-old lawsuit that alleges...
Aug 19, 2021 · Founder Satish Mehta traces the four-decade journey of the homegrown pharma major. Second-generation entrepreneur Satish Mehta started Emcure Pharmaceuticals decades before ‘Made in India’ or...
Emcure Pharmaceuticals was established in 1981 by Satish Mehta, who began the company with a bank loan of ₹ 3 lakh (about US$35,000 then) after graduating from IIM-A. [9] In the 1990s, the company transitioned from being a contract manufacturing organization to a producer of generic drugs. [10]
Oct 4, 2017 · Pharma distributor's son Satish Mehta founded and runs Emcure Pharmaceuticals, which has private equity firm Bain Capital as an investor.
Jul 12, 2024 · Satish Ranamnlal Mehta is the founder of Emcure Pharmaceuticals and also serves as the CEO and Managing Director of the company. He is a postgraduate in Chemistry from Pune University and has a diploma in management from the IIM, Ahmedabad.
Satish Mehta, MD & CEO of Emcure Pharmaceuticals is having his moment under the sun. Emcure’s subsidiary, Gennova, is working on India’s first indigenously developed mRNA COVID-19 vaccine. Phase-2 and Phase-3 trials are currently underway. Satish Mehta is a 1975 batch graduate of IIM Ahmedabad, and his father, Raman Lal, was a pharma retailer.
Aug 20, 2021 · Second-generation entrepreneur Satish Mehta started Emcure Pharmaceuticals decades before ‘Made in India’ or ‘Build in India’ became catchphrases. Driven by the urge to do something on his...
Satish Mehta is the founder and CEO of Emcure Pharmaceuticals, an Indian multinational pharmaceutical company. He was born in a family of pharma retailers in Pune, India. He is an alumnus of Pune University and Indian Institute of Management, Ahmedabad.
Aug 9, 2021 · Satish Mehta, founder and CEO of Emcure Pharmaceuticals, says that while he is satisfied with the primary outcome on safety of the vaccine, he will soon submit the data with CDSCO and apply for next phase trials.
